SARS-CoV-2 reduces TIMP3 mRNA expression in alveolar epithelial cells, that likely promotes greater ADAM17 activity in COVID-19 patients.PTEN signalling is increased after SARS-CoV-2 infection. The gene discussed is ADAM17; the disease is COVID-19.